A Customized Pigmentation SNP Array Identifies a Novel SNP Associated with Melanoma Predisposition in the SLC45A2 Gene
2011

Genetic Variants Linked to Melanoma Risk in Spanish Population

Sample size: 1214 publication 10 minutes Evidence: high

Author Information

Author(s): Ibarrola-Villava Maider, Fernandez Lara P., Alonso Santos, Boyano M. Dolores, Peña-Chilet Maria, Pita Guillermo, Aviles Jose A., Mayor Matias, Gomez-Fernandez Cristina, Casado Beatriz, Martin-Gonzalez Manuel, Izagirre Neskuts, De la Rua Concepcion, Asumendi Aintzane, Perez-Yarza Gorka, Arroyo-Berdugo Yoana, Boldo Enrique, Lozoya Rafael, Torrijos-Aguilar Arantxa, Pitarch Ana, Pitarch Gerard, Sanchez-Motilla Jose M., Valcuende-Cavero Francisca, Tomas-Cabedo Gloria, Perez-Pastor Gemma, Diaz-Perez Jose L., Gardeazabal Jesus, de Lizarduy Iñigo Martinez, Sanchez-Diez Ana, Valdes Carlos, Pizarro Angel, Casado Mariano, Carretero Gregorio, Botella-Estrada Rafael, Nagore Eduardo, Lazaro Pablo, Lluch Ana, Benitez Javier, Martinez-Cadenas Conrado, Ribas Gloria

Primary Institution: Fundacion Hospital Clinico Universitario-INCLIVA, Valencia, Spain

Hypothesis

Variations in genes related to pigmentation may be associated with susceptibility to malignant melanoma.

Conclusion

A novel SNP in the SLC45A2 gene is significantly associated with melanoma risk, suggesting its protective role.

Supporting Evidence

  • Two SNPs in the SLC45A2 gene were statistically significant after Bonferroni correction.
  • Individuals with two or more mutations in MC1R had decreased melanoma risk if they also carried the SLC45A2 protective variant.
  • The study is the largest on Spanish sporadic melanoma cases to date.

Takeaway

This study found a gene that helps protect against skin cancer in people with certain skin colors.

Methodology

The study genotyped 363 SNPs in 65 pigmentation-related gene regions in two phases involving 1214 melanoma cases and 1296 controls.

Limitations

The study is limited to a Spanish population and may not be generalizable to other ethnic groups.

Participant Demographics

Participants included 1214 melanoma cases and 1296 controls from various Spanish hospitals.

Statistical Information

P-Value

p<0.0001

Confidence Interval

95% CI 0.67–0.84

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1371/journal.pone.0019271

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication